Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial (Tobacco Education and Lung Health Study)
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Phase 3
SUMMARY
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Maximum Age: 80
Healthy Volunteers: f
View:
• eligible for a screening or diagnostic scan,
• USPSTF eligibility criteria (50-80 years old and \>20-pack years);
• currently smoking cigarettes (\>1 in the past 30 days);
• English speaking;
• able to provide meaningful consent.
Locations
United States
Washington, D.c.
Georgetown University Medical Center
RECRUITING
Washington D.c.
Contact Information
Primary
Kathryn L Taylor, PhD
taylorkl@georgetown.edu
2022159402
Backup
Randi M. Williams, PhD
rmw27@georgetown.edu
Time Frame
Start Date: 2024-02-22
Estimated Completion Date: 2026-04
Participants
Target number of participants: 1188
Treatments
Experimental: MedStar Health System
Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention
Active_comparator: E-Referral to the Tobacco Quitline
Standard tobacco quitline protocol, including coaching, nicotine replacement, and web-, and text-based resources.
Related Therapeutic Areas
Sponsors
Leads: Georgetown University